Patents by Inventor Robert Turner

Robert Turner has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9745297
    Abstract: The present invention encompasses compounds of the formula (I), wherein the variables are defined herein which are suitable for the modulation of RORC and the treatment of diseases related to the modulation of RORC. The present invention also encompasses processes of making compounds of formula (I) and pharmaceutical preparations containing them.
    Type: Grant
    Filed: July 28, 2014
    Date of Patent: August 29, 2017
    Assignee: Boehringer Ingelheim International GmbH
    Inventors: Brian Nicholas Cook, John D. Huber, Robert Owen Hughes, Xiang Li, Shuang Liang, Ingo Andreas Mugge, Michael Robert Turner, Qiang Zhang
  • Publication number: 20170222429
    Abstract: The present invention is concerned with pre-magnetizing a Modular Multilevel power Converters connected transformer in order to moderate inrush currents upon connecting the transformer to an electric grid. The invention takes advantage of the high amount of stored energy in MMC converters as compared to other converter types. This stored energy is used to pre-magnetize the converter-connected transformer, therefore no additional or dedicated pre-magnetizing hardware is required in addition to the charging hardware provided to charge the converter capacitors. As the transformer pre-magnetizing takes place subsequent to the converter charging, the converter charging circuit is not used to, and therefore does not need to be designed to, directly magnetize the transformer.
    Type: Application
    Filed: April 17, 2017
    Publication date: August 3, 2017
    Inventor: Robert TURNER
  • Patent number: 9672351
    Abstract: A method of producing a control stack includes: writing a plurality of control information entries into a control stack buffer that is internal to a processor in response to one or more function calls; and in response to the control stack buffer being full and receiving a further function call, writing: the plurality of control information entries to an external memory that is external to the processor; and a further control information entry, corresponding to the further function call, to the control stack buffer.
    Type: Grant
    Filed: February 2, 2015
    Date of Patent: June 6, 2017
    Assignee: QUALCOMM Incorporated
    Inventors: Arvind Krishnaswamy, Can Acar, Robert Turner
  • Publication number: 20170137870
    Abstract: The present invention includes methods, devices and systems for isolating a nucleic acid from a fluid comprising cells. In various aspects, the methods, devices and systems may allow for a rapid procedure that requires a minimal amount of material and/or results in high purity nucleic acid isolated from complex fluids such as blood or environmental samples.
    Type: Application
    Filed: June 19, 2015
    Publication date: May 18, 2017
    Inventors: Rajaram KRISHNAN, David J. CHARLOT, Eugene TU, James MCCANNA, Lucas KUMOSA, Paul D. SWANSON, Robert TURNER, Kai YANG, Irina DOBROVOLSKAYA, David LIU, Juan Pablo HINESTROSA SALAZAR, Juscilene MENEZES
  • Publication number: 20170082515
    Abstract: A pressure overload protector for a sensor includes a pressure-filled channel system fillable with fluid or gas, a first overload stop seated in an open position, a first diaphragm at the unseated end of the first overload stop, a second overload stop seated in an open position, a second diaphragm at the unseated end of the second overload stop, a sensor connected to a fluid channel, and a third and fourth overload stop connected by channels to the fluid channel of the sensor and terminating at a fluid exit. The overload protector provides bidirectional over and under pressure protection to the sensor.
    Type: Application
    Filed: September 18, 2015
    Publication date: March 23, 2017
    Applicant: TECSIS GMBH
    Inventors: Robert TURNER, Pavel GVANTMAKHER, Reinhold OST, Bruce YOHR, Mark JONES
  • Patent number: 9598415
    Abstract: The present invention encompasses compounds of the formula (I) wherein the variables are defined herein which are suitable for the modulation of ROR? and the treatment of diseases related to the modulation of ROR?. The present invention also encompasses processes of making compounds of formula (I) and pharmaceutical preparations containing them.
    Type: Grant
    Filed: September 20, 2016
    Date of Patent: March 21, 2017
    Assignee: Boehringer Ingelheim International GmbH
    Inventors: Johanna Bakonyi, Steven Richard Brunette, Delphine Collin, Robert Owen Hughes, Xiang Li, Shuang Liang, Robert Sibley, Michael Robert Turner, Lifen Wu, Qiang Zhang
  • Publication number: 20170072395
    Abstract: The present invention includes methods, devices and systems for isolating a nucleic acid from a fluid comprising cells. In various aspects, the methods, devices and systems may allow for a rapid procedure that requires a minimal amount of material and/or results in high purity nucleic acid isolated from complex fluids such as blood or environmental samples.
    Type: Application
    Filed: October 13, 2016
    Publication date: March 16, 2017
    Inventors: Rajaram KRISHNAN, David CHARLOT, Eugene TU, James MCCANNA, Lucas KUMOSA, Paul SWANSON, Robert TURNER, Kai YANG, Irina DOBROVOLSKAYA, David LIU
  • Publication number: 20170008894
    Abstract: The present invention encompasses compounds of the formula (I) wherein the variables are defined herein which are suitable for the modulation of ROR? and the treatment of diseases related to the modulation of ROR?. The present invention also encompasses processes of making compounds of formula (I) and pharmaceutical preparations containing them.
    Type: Application
    Filed: September 20, 2016
    Publication date: January 12, 2017
    Inventors: Johanna BAKONYI, Steven Richard BRUNETTE, Delphine COLLIN, Robert Owen HUGHES, Xiang LI, Shuang LIANG, Robert SIBLEY, Michael Robert TURNER, Lifen WU, Qiang ZHANG
  • Patent number: 9514305
    Abstract: Techniques for enforcing flow control of a software program in a processor are provided. An example method according to these techniques includes analyzing program code of the software program to identify a code pointer in the program code, generating an authentication tag based on the code pointer, and modifying the code pointer in the program code with the authentication tag to generate a tagged code pointer.
    Type: Grant
    Filed: October 17, 2014
    Date of Patent: December 6, 2016
    Assignee: QUALCOMM Incorporated
    Inventors: Can Acar, Arvind Krishnaswamy, Robert Turner
  • Patent number: 9499812
    Abstract: The present invention includes methods, devices and systems for isolating a nucleic acid from a fluid comprising cells. In various aspects, the methods, devices and systems may allow for a rapid procedure that requires a minimal amount of material and/or results in high purity nucleic acid isolated from complex fluids such as blood or environmental samples.
    Type: Grant
    Filed: October 28, 2015
    Date of Patent: November 22, 2016
    Assignee: BIOLOGICAL DYNAMICS, INC.
    Inventors: Rajaram Krishnan, David Charlot, Eugene Tu, James McCanna, Lucas Kumosa, Paul Swanson, Robert Turner, Kai Yang, Irina Dobrovolskaya, David Liu
  • Publication number: 20160243102
    Abstract: Disclosed are novel substituted 2H-isoquinolin-1-one and 3H-quinazolin-4-one derivatives useful as inhibitors of Rho kinase and for treating a variety of diseases and disorders that are mediated or sustained through the activity of Rho kinase, including cardiovascular diseases, pharmaceutical compositions comprising such compounds, methods for using such compounds and processes for making such compounds.
    Type: Application
    Filed: April 29, 2016
    Publication date: August 25, 2016
    Inventors: Todd Bosanac, John David Ginn, Eugene Richard Hickey, Thomas Martin Kirrane, JR., Weimin Liu, Anthony S. Prokopowicz, Sabine K. Schlyer, Cheng-Kon Shih, Roger John Snow, Michael Robert Turner, Frank Wu, Erick Richard Young
  • Publication number: 20160229547
    Abstract: A turboprop control system 10 for use with a turboprop 2 having a turbine engine 12 operably coupled to and rotationally driving a propeller 14 having variable pitch blades 16 to control the engine speed, propeller speed, and propeller pitch. The pilot provides, by a single power control lever 30, the control input used to control the engine and propeller.
    Type: Application
    Filed: September 23, 2014
    Publication date: August 11, 2016
    Inventors: Edward Aaron FISHER, Scott Brian WRIGHT, James Robert TURNER
  • Publication number: 20160224784
    Abstract: A method of producing a control stack includes: writing a plurality of control information entries into a control stack buffer that is internal to a processor in response to one or more function calls; and in response to the control stack buffer being full and receiving a further function call, writing: the plurality of control information entries to an external memory that is external to the processor; and a further control information entry, corresponding to the further function call, to the control stack buffer.
    Type: Application
    Filed: February 2, 2015
    Publication date: August 4, 2016
    Inventors: Arvind KRISHNASWAMY, Can ACAR, Robert TURNER
  • Patent number: 9403830
    Abstract: The present invention relates to compounds of formula (I): or a pharmaceutically acceptable salt thereof, wherein A1, A2, L1 and B are as defined herein. The compounds of formula (I) are useful as inhibitors of leukotriene A4 hydrolase (LTA4H) and treating LTA4H related disorders. The present invention also relates to pharmaceutical compositions comprising the compounds of formula (I), methods of using these compounds in the treatment of various diseases and disorders, and processes for preparing these compounds.
    Type: Grant
    Filed: July 16, 2013
    Date of Patent: August 2, 2016
    Assignee: Boehringer Ingelheim International GmbH
    Inventors: Asitha Abeywardane, Steven Richard Brunette, Michael Jason Burke, Thomas Martin Kirrane, Jr., Chuk Chui Man, Daniel Richard Marshall, Anil Kumar Padyana, Hossein Razavi, Robert Sibley, Lana Louise Smith Keenan, Roger John Snow, Ronald John Sorcek, Hidenori Takahashi, Steven John Taylor, Michael Robert Turner, Erick Richard Roush Young, Qiang Zhang, Yunlong Zhang, Renee M. Zindell
  • Publication number: 20160159791
    Abstract: The present invention encompasses compounds of the formula (I), wherein the variables are defined herein which are suitable for the modulation of RORC and the treatment of diseases related to the modulation of RORC. The present invention also encompasses processes of making compounds of formula (I) and pharmaceutical preparations containing them.
    Type: Application
    Filed: July 28, 2014
    Publication date: June 9, 2016
    Inventors: Brian Nicholas COOK, John D. HUBER, Robert Owen HUGHES, Xiang LI, Shuang LIANG, Ingo Andreas MUGGE, Michael Robert TURNER, Qiang ZHANG
  • Publication number: 20160123232
    Abstract: A method of starting a turbine engine using turbine temperature gradient regulation and a turbine engine temperature management system are provided. The system includes a temperature sensor, a modulating fuel flow valve, and a temperature controller. The temperature controller is configured to limit a rate of change of the fuel flow to the turbine engine to less than a predetermined maximum rate of change of the fuel flow that will reduce a rate of change of the temperature and maintain a positive rate of change of a rotational speed of the turbine engine and limit a rate of the fuel flow to greater than a predetermined minimum rate of the fuel flow that maintains a positive rate of change of temperature and a positive rate of change of the rotational speed of the turbine engine.
    Type: Application
    Filed: November 4, 2014
    Publication date: May 5, 2016
    Inventors: Scott Brian Wright, James Robert Turner
  • Publication number: 20160110545
    Abstract: Techniques for enforcing flow control of a software program in a processor are provided. An example method according to these techniques includes analyzing program code of the software program to identify a code pointer in the program code, generating an authentication tag based on the code pointer, and modifying the code pointer in the program code with the authentication tag to generate a tagged code pointer.
    Type: Application
    Filed: October 17, 2014
    Publication date: April 21, 2016
    Inventors: Can ACAR, Arvind KRISHNASWAMY, Robert TURNER
  • Publication number: 20160075706
    Abstract: The present invention encompasses compounds of the formula (I) wherein the variables are defined herein which are suitable for the modulation of ROR? and the treatment of diseases related to the modulation of ROR?. The present invention also encompasses processes of making compounds of formula (I) and pharmaceutical preparations containing them.
    Type: Application
    Filed: November 20, 2015
    Publication date: March 17, 2016
    Inventors: Johanna BAKONYI, Steven Richard BRUNETTE, Delphine COLLIN, Robert Owen HUGHES, Xiang LI, Shuang LIANG, Robert SIBLEY, Michael Robert TURNER, Lifen WU, Qiang ZHANG
  • Publication number: 20160046926
    Abstract: The present invention includes methods, devices and systems for isolating a nucleic acid from a fluid comprising cells. In various aspects, the methods, devices and systems may allow for a rapid procedure that requires a minimal amount of material and/or results in high purity nucleic acid isolated from complex fluids such as blood or environmental samples.
    Type: Application
    Filed: October 28, 2015
    Publication date: February 18, 2016
    Inventors: Rajaram KRISHNAN, David CHARLOT, Eugene TU, James MCCANNA, Lucas KUMOSA, Paul SWANSON, Robert TURNER, Kai YANG, Irina DOBROVOLSKAYA, David LIU
  • Patent number: 9242989
    Abstract: The present invention encompasses compounds of the formula (I) wherein the variables are defined herein which are suitable for the modulation of ROR? and the treatment of diseases related to the modulation of ROR?. The present invention also encompasses processes of making compounds of formula (I) and pharmaceutical preparations containing them.
    Type: Grant
    Filed: April 10, 2015
    Date of Patent: January 26, 2016
    Assignee: Boehringer Ingelheim International GmbH
    Inventors: Johanna Bakonyi, Steven Richard Brunette, Delphine Collin, Robert Owen Hughes, Xiang Li, Shuang Liang, Robert Sibley, Michael Robert Turner, Lifen Wu, Qiang Zhang